| Class 3 Device Recall 37 Etching Gel3ml syringe | |
Date Initiated by Firm | March 31, 2011 |
Date Posted | November 03, 2011 |
Recall Status1 |
Terminated 3 on August 09, 2012 |
Recall Number | Z-0156-2012 |
Recall Event ID |
60114 |
510(K)Number | K874189 |
Product Classification |
Material, tooth shade, resin - Product Code EBF
|
Product | 37% Etching Gel-3ml syringe, part #N01H
The intended use of these devices is to etch tooth dentin/enamel in order to prepare the tooth surface prior to the application of a bonding agent. |
Code Information |
all lots of products labeled as 37% Phosphoric Acid Etching Gel produced since April 2007 |
Recalling Firm/ Manufacturer |
Kerr/pentron Dba Kerr Corporation And Pentron Clinical 1717 W. Collins Ave Orange CA 92867
|
For Additional Information Contact | 714-516-7400 |
Manufacturer Reason for Recall | Pentron Clinical is voluntarily recalling all lots of products labeled as 37% Phosphoric Acid Etching Gel produced since April 2007 because the product continues to extrude out of the syringe even after pressure is no longer applied, and it contains a higher percentage of phosphoric acid than that indicated on the label. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | The firm, Pentron Clinical, sent an "URGENT: MEDICAL DEVICE RECALL" letter dated May 31, 2011, with attached Return Form (via USPS 1st class mail) to all their consignees/customers. The letter describes the product, problem and action to be taken.
All consignees/customers were instructed to complete the Recall Return Form via fax to: 1-877-677-8844 and to return any affected product in their inventory. Affected products will have expiration dates between April 2011 and April 2015.
Consignees/customers with questions can contact Pentron Clinical Customer Service at (800) 551-0283 directly to handle the arrangements of a quick return and replacement. |
Quantity in Commerce | 41,744 units |
Distribution | Worldwide distribution: USA (nationwide) and countries of: Armenia, Austria, Australia, Antigua & Barbuda, Barbados, Belarus, Bulgaria, Canada, Czech Republic, Croatia, Cyprus, Ecuador, El Salvador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Kenya, Latvia, Lebanon, Malaysia, Mexico, Morocco, Netherlands, Poland, Romania, Russia, St. Vincent & Grenadine, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Taiwan, Thailand, Turkey, UAE, Ukraine, UK, and Vietnam. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = EBF
|
|
|
|